An incurable disease
A new book explains how health care can become both more expensive and more affordable
HEALTH-CARE expenditure in America is growing at a disturbing rate: in 1960 it was just over 5% of GDP, in 2011 almost 18%. By 2105 the number could reach 60%, according to William Baumol of New York University’s Stern School of Business. Incredible? It is simply the result of extrapolating the impact of a phenomenon Mr Baumol has become famous for identifying: “cost disease”. His new book* gives a nuanced diagnosis, offerings both a vision of a high-cost future and a large dose of optimism. The cost disease may be incurable, but it is also survivable—if treated correctly.
This article appeared in the Finance & economics section of the print edition under the headline “An incurable disease”

From the September 29th 2012 edition
Discover stories from this section and more in the list of contents
Explore the edition
Want to be a good explorer? Study economics
The battle to reduce risk has shaped centuries of ventures

Jane Street is chucked out of India. Other firms should be nervous
Around the world, marketmakers now face extra scrutiny

Japan has been hit by investing fever
Will old folk catch the bug?
Don’t invest through the rearview mirror
Markets are supposed to look forward; plenty of investors look back instead
Trump’s trade deals try a creative way to hobble China
To appease the world’s biggest market, countries must anger the world’s biggest trader
The great dealmaker is conspicuously short of trade deals
Donald Trump issues threats—and grants deadline extensions